Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Since 1995, the outlook for patients with hiv infection has improved significantly with the advent of triple-drug-potent antiretroviral (ARV) therapy regimens.

HIV Integrase Inhibitors Show Potent Activity in Clinical Trials